Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) Liabilities and Shareholders Equity (2016 - 2026)

Updated

Analysis

Krystal Biotech (KRYS) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn 1.59 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.59 Bn
Jun 30, 2026 1.50 Bn
Mar 31, 2026 1.40 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 1.24 Bn
Jun 30, 2025 1.14 Bn
Mar 31, 2025 1.07 Bn
Dec 31, 2024 1.06 Bn
Sep 30, 2024 982.32 Mn
Jun 30, 2024 917.66 Mn
Mar 31, 2024 853.30 Mn
Dec 31, 2023 818.36 Mn
Sep 30, 2023 790.35 Mn
Jun 30, 2023 684.03 Mn
Mar 31, 2023 531.85 Mn
Dec 31, 2022 558.45 Mn
Sep 30, 2022 576.38 Mn
Jun 30, 2022 601.32 Mn
Mar 31, 2022 616.87 Mn
Dec 31, 2021 626.30 Mn
API Access

Krystal Biotech Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KRYS&period=max&api_key=YOUR_API_KEY